66790 Federal Register / Vol. 71, No. 221 / Thursday, November 16, 2006 / Notices 

Dated: November 7, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9209 Filed 11–15–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Neural Tube 

Defects. 

Date: November 28, 2006. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Anne Krey, Scientific 

Review Administrator, Division of Scientific 

Review, National Institute of Child Health 

and Human Development, National Institutes 

of Health, Bethesda, MD 20892, 301–435–

6908. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel Children Living in 

Rural Poverty: The Continuation of the 

Family Life Project. 

Date: November 30, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Jefferson, 2500 Calvert Street, 

NW., Washington, DC 20037. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, 6100 

Building, Room 5B01, Bethesda, MD 20892, 

(301) 435–6911, hopmannm@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, A Prospective Study 

of Diet and Fibroids in Black Women. 

Date: November 30, 2006. 

Time: 10 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Room 5B01, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Jon M. Ranhand, PhD, 

Scientist Review Administrator, Division of 

Scientific Review, National institute of Child 

Health and Human Development, NIH, 6100 

Executive Boulevard, Room 5B01, Bethesda, 

MD 20892, (301) 435–6884, 

ranhandj@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel Environmental & 

Biological Variation and Language Growth. 

Date: December 5, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Jefferson Hotel, 1200 Sixteenth 

Street, NW., Washington, DC 20036. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health, and Human Development, 6100 

Building, Room 5B01, Bethesda, MD 20892, 

(301) 435–6911, hopmannm@mail.nih.gov. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel Translational 

Analyses of Chronic Aberrant Behavior 

Across the Life Span. 

Date: December 6, 2006. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Marita R. Hopmann, PhD, 

Scientific Review Administrator, Division of 

Scientific Review, National Institute of Child 

Health, and Human Development, 6100 

Building, Room 5B01, Bethesda, MD 20892, 

(301) 435–6911, hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: November 7, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9210 Filed 11–15–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Drug Testing Advisory Board; Notice 

of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given of the meeting of 

the Substance Abuse and Mental Health 

Services Administration (SAMHSA) 

Drug Testing Advisory Board in 

December 2006. 

A portion of the meeting will be open 

and will include, but not limited to, a 

Department of Health and Human 

Services drug testing program update, a 

Department of Transportation drug 

testing program update, a Nuclear 

Regulatory Commission drug testing 

program update, an update on the pilot 

performance testing programs for hair 

and oral fluid, results from a Medical 

Review Officer data source, and results 

from a study on the external 

contamination of hair with cocaine. 

Attendance by the public will be 

limited to space available. Public 

comments are welcome. Please 

communicate with Dr. Donna Bush, 

Executive Secretary (see contact 

information below), to make 

arrangements to comment or to request 

special accommodations for persons 

with disabilities. 

The Board will also meet to develop 

the final revisions to the proposed 

Mandatory Guidelines for Federal 

Workplace Drug Testing Programs that 

were published in the Federal Register 

on April 13, 2004 (69 FR 19673). This 

meeting will be conducted in closed 

session since discussing these issues in 

open session will significantly frustrate 

the Department’s ability to develop the 

revisions to the Mandatory Guidelines. 

The HHS Office of General Counsel 

made the determination that such 

matters are protected by exemption 9(B) 

of section 552b(c) of title 5 U.S.C. and, 

therefore, may be closed to the public. 

To facilitate entering the building for 

the open session, public attendees are 

required to contact Mrs. Giselle Hersh, 

Division of Workplace Programs, 1 

Choke Cherry Road, Room 2–1042, 

Rockville, MD 20857, 240–276–2605 

(telephone) or by e-mail to 

Giselle.Hersh@samhsa.hhs.gov. 

Substantive program information and 

a roster of Board members may be 

obtained by contacting Dr. Bush or by 

accessing the SAMHSA workplace Web 

site (http://workplace.samhsa.gov). The 

transcript for the open session will be 

available on the SAMHSA workplace 

Web site within 3 weeks after the 

meeting. 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration Drug Testing Advisory 

Board. 

Meeting Date: December 12–13, 2006. 

Place: SAMHSA Building, Rock Creek 

Room 1, Choke Cherry Road, Rockville, 

Maryland 20850. 

Type: Open: December 12, 2006; 8:30 

a.m.–4:30 p.m. 


pwalker on PROD1PC61 with NOTICES